Novel Entries in a Fungal Biofilm Matrix Encyclopedia
Open accessThe DOI matches its Crossref record; 95 of the 98 references it cites were found in a registry or an index.
Abstract
Virulence of Candida is linked with its ability to form biofilms. Once established, biofilm infections are nearly impossible to eradicate. Biofilm cells live immersed in a self-produced matrix, a blend of extracellular biopolymers, many of which are uncharacterized. In this study, we provide a comprehensive analysis of the matrix manufactured by Candida albicans both in vitro and in a clinical niche animal model. We further explore the function of matrix components, including the impact on drug resistance. We uncovered components from each of the macromolecular classes (55% protein, 25% carbohydrate, 15% lipid, and 5% nucleic acid) in the C. albicans biofilm matrix. Three individual polysaccharides were identified and were suggested to interact physically. Surprisingly, a previously identified polysaccharide of functional importance, β-1,3-glucan, comprised only a small portion of the total matrix carbohydrate. Newly described, more abundant polysaccharides included α-1,2 branched α-1,6-mannans (87%) associated with unbranched β-1,6-glucans (13%) in an apparent mannan-glucan complex (MGCx). Functional matrix proteomic analysis revealed 458 distinct activities. The matrix lipids consisted of neutral glycerolipids (89.1%), polar glycerolipids (10.4%), and sphingolipids (0.5%). Examination of matrix nucleic acid identified DNA, primarily noncoding sequences. Several of the in vitro matrix components, including proteins and each of the polysaccharides, were also present in the matrix of a clinically relevant in vivo biofilm. Nuclear magnetic resonance (NMR) analysis demonstrated interaction of aggregate matrix with the antifungal fluconazole, consistent with a role in drug impedance and contribution of multiple matrix components. IMPORTANCE This report is the first to decipher the complex and unique macromolecular composition of the Candida biofilm matrix, demonstrate the clinical relevance of matrix components, and show that multiple matrix components are needed for protection from antifungal drugs. The availability of these biochemical analyses provides a unique resource for further functional investigation of the biofilm matrix, a defining trait of this lifestyle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Proteins are estimated to contribute greater than 50% of the biomass of C. albicans biofilms, and include enzymes in metabolic pathways for carbohydrates, amino acids, and energy metabolism.98”
From The dental plaque biofilm matrix (2021) · cites this paper as [98]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the biofilm community, a unique extracellular mannan-glucan complex has been shown to prevent antifungal drugs from reaching intracellular drug targets (17–20).”
From Dual function of Candida auris mannosyltransferase, MNT5, in biofilm community protection from antifungal therapy and the host (2025) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The C. albicans biofilm matrix is predominantly composed of proteins and glycoproteins (55%), carbohydrates (25%), lipids (15%), and nucleic acids (5%).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [209]
The cited source says what the claim attributes to it.
In the citing paper
“Over 500 proteins were identified in the matrix.”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [209]
The cited source says what the claim attributes to it.
In the citing paper
“Thus, although β-1,3-glucans contribute to drug resistance and are the major cell wall polysaccharide (130), we now know that they constitute only a small fraction of the total polysaccharides present, implying that the matrix is not constructed simply of released cell wall constituents.”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [209]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 2×
“The biofilm lifestyle represents a common form of microbial growth and persistence in nature (1, 29, 30).”
BackgroundFlemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Perkins, D. N., Pappin, D. J. C., Creasy, D. M., & Cottrell, J. S. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19991201)20:18<3551::aid-elps3551>3.0.co;2-2 · Cited by 8,203
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 2×
“Arguably, the most clinically relevant phenotype of biofilm growth in the medical setting is resistance to antimicrobial therapy and the immune system (2, 59, 60).”
BackgroundKEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848
Keller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“Candida albicans is the most common hospital-associated fungal pathogen and frequently produces biofilm infection of medical devices, resulting in the highest mortality among nosocomial pathogens (6, 7).”
BackgroundMechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
A colorimetric method for the determination of sugars
DUBOIS, M., GILLES, K., HAMILTON, J. K., REBERS, P. A., & SMITH, F. (1951) · Nature · doi:10.1038/168167a0 · Cited by 2,504
Hwang, T. L., & Shaka, A. J. (1995) · Journal of Magnetic Resonance, Series A · doi:10.1006/jmra.1995.1047 · Cited by 1,898
Biofilm exopolysaccharides: a strong and sticky framework
Sutherland, I. W. (2001) · Microbiology · doi:10.1099/00221287-147-1-3 · Cited by 1,801
The EPS Matrix: The “House of Biofilm Cells”
Flemming, H.-C., Neu, T. R., & Wozniak, D. J. (2007) · Journal of Bacteriology · doi:10.1128/jb.00858-07 · Cited by 1,794
Biofilms: the matrix revisited
Branda, S. S., Vik, Å., Friedman, L., & Kolter, R. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.006 · Cited by 1,791
Biofilm Formation: A Clinically Relevant Microbiological Process
Donlan, R. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322972 · Cited by 1,343
The biofilm matrix – an immobilized but dynamic microbial environment
Sutherland, I. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02012-1 · Cited by 1,265
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T.-F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S., & O'Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055 · cited 1×
“albicans, resistance to external threats, such as antifungals, is one clinically relevant role (13, 26, 27).”
BackgroundRhamnolipid Surfactant Production Affects Biofilm Architecture in Pseudomonas aeruginosa PAO1
Davey, M. E., Caiazza, N. C., & O'Toole, G. A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.3.1027-1036.2003 · Cited by 804
Cell Wall and Secreted Proteins of Candida albicans: Identification, Function, and Expression
Chaffin, W. L., López-Ribot, J. L., Casanova, M., Gozalbo, D., & Martínez, J. P. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.130-180.1998 · Cited by 726
A major protein component of the Bacillus subtilis biofilm matrix
Branda, S. S., Chu, F., Kearns, D. B., Losick, R., & Kolter, R. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.05020.x · Cited by 706
Mechanisms of regulated unconventional protein secretion
Nickel, W., & Rabouille, C. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2617 · Cited by 702
Colvin, K. M., Irie, Y., Tart, C. S., Urbano, R., Whitney, J. C., Ryder, C., Howell, P. L., Wozniak, D. J., & Parsek, M. R. (2012) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02657.x · Cited by 612
A Fatty Acid Messenger Is Responsible for Inducing Dispersion in Microbial Biofilms
Davies, D. G., & Marques, C. N. H. (2009) · Journal of Bacteriology · doi:10.1128/jb.01214-08 · Cited by 603
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583 · cited 1×
“Arguably, the most clinically relevant phenotype of biofilm growth in the medical setting is resistance to antimicrobial therapy and the immune system (2, 59, 60).”
BackgroundColvin, K. M., Gordon, V. D., Murakami, K., Borlee, B. R., Wozniak, D. J., Wong, G. C. L., & Parsek, M. R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001264 · Cited by 577
Forging a Link Between Biofilms and Disease
Potera, C. (1999) · Science · doi:10.1126/science.283.5409.1837 · Cited by 548
Al-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
Mukherjee, P. K., Chandra, J., Kuhn, D. M., & Ghannoum, M. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4333-4340.2003 · Cited by 511 · cited 1×
“The mechanism underlying this phenotype is multifactorial (12, 23, 61, 62).”
BackgroundCritical Role of Bcr1-Dependent Adhesins in C. albicans Biofilm Formation In Vitro and In Vivo
Nobile, C. J., Andes, D. R., Nett, J. E., Smith, F. J., Yue, F., Phan, Q.-T., Edwards, J. E., Filler, S. G., & Mitchell, A. P. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020063 · Cited by 507
Self-citationRamage, G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf049 · Cited by 468
Regulation of Cell-Surface Genes and Biofilm Formation by the C. albicans Transcription Factor Bcr1p
Nobile, C. J., & Mitchell, A. P. (2005) · Current Biology · doi:10.1016/j.cub.2005.05.047 · Cited by 464
Self-citationPutative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-06 · Cited by 407
Self-citationAndes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., & Pitula, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6023-6031.2004 · Cited by 389
Self-citationCandida albicans Als3, a multifunctional adhesin and invasin
Liu, Y., & Filler, S. G. (2011) · Eukaryotic Cell · doi:10.1128/ec.00279-10 · Cited by 354
Biofilm Matrix Regulation by Candida albicans Zap1
Nobile, C. J., Nett, J. E., Hernday, A. D., Homann, O. R., Deneault, J.-S., Nantel, A., Andes, D. R., Johnson, A. D., & Mitchell, A. P. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000133 · Cited by 337
Self-citationThe cell wall architecture of Candida albicans wild‐type cells and cell wall‐defective mutants
Kapteyn, J. C., Hoyer, L. L., Hecht, J. E., Müller, W. H., Andel, A., Verkleij, A. J., Makarow, M., Van Den Ende, H., & Klis, F. M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01729.x · Cited by 328
Fourier transform ion cyclotron resonance mass spectrometry
Marshall, A. G. (1985) · Accounts of Chemical Research · doi:10.1021/ar00118a006 · Cited by 322
Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291
Self-citationA Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance
Taff, H. T., Nett, J. E., Zarnowski, R., Ross, K. M., Sanchez, H., Cain, M. T., Hamaker, J., Mitchell, A. P., & Andes, D. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002848 · Cited by 291 · cited 4×
“We identified three glucan hydrolyzing enzymes that have been shown to deliver and potentially degrade matrix components (Xog1p, Bgl2p, Exg1p), which is consistent with this theory (13).”
BackgroundResultSelf-citationMartin, S. E., Shabanowitz, J., Hunt, D. F., & Marto, J. A. (2000) · Analytical Chemistry · doi:10.1021/ac000497v · Cited by 276
In vivo biofilm composition of Aspergillus fumigatus
Loussert, C., Schmitt, C., Prevost, M.-C., Balloy, V., Fadel, E., Philippe, B., Kauffmann-Lacroix, C., Latgé, J. P., & Beauvais, A. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01409.x · Cited by 269 · cited 2×
“Studies with both Aspergillus fumigatus and Saccharomyces cerevisiae analyses have identified both glucan- and mannan-containing materials (34, 35).”
BackgroundSassaki, G. L., Gorin, P. A. J., Souza, L. M., Czelusniak, P. A., & Iacomini, M. (2005) · Carbohydrate Research · doi:10.1016/j.carres.2005.01.020 · Cited by 262
Genetic Basis of Candida Biofilm Resistance Due to Drug‐Sequestering Matrix Glucan
Nett, J. E., Sanchez, H., Cain, M. T., & Andes, D. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/651200 · Cited by 250
Self-citationMartins, M., Uppuluri, P., Thomas, D. P., Cleary, I. A., Henriques, M., Lopez-Ribot, J. L., & Oliveira, R. (2010) · Mycopathologia · doi:10.1007/s11046-009-9264-y · Cited by 250
Penetration of Candida Biofilms by Antifungal Agents
Al-Fattani, M. A., & Douglas, L. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3291-3297.2004 · Cited by 235
Non-conventional protein secretionin yeast
Nombela, C., Gil, C., & Chaffin, W. L. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2005.11.009 · Cited by 212
Nett, J. E., Crawford, K., Marchillo, K., & Andes, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-10 · Cited by 207 · cited 1×
“albicans, both the matrix polysaccharide, -1,3-glucan, and extracellular DNA have been demonstrated to contribute to the drug resistance mechanism (11, 23, 28, 63).”
BackgroundSelf-citationInglis, D. O., Arnaud, M. B., Binkley, J., Shah, P., Skrzypek, M. S., Wymore, F., Binkley, G., Miyasato, S. R., Simison, M., & Sherlock, G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr945 · Cited by 199
Andes, D., & van Ogtrop, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2116 · Cited by 192
Self-citationVediyappan, G., Rossignol, T., & d'Enfert, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01638-09 · Cited by 183
Shibata, N., Suzuki, A., Kobayashi, H., & Okawa, Y. (2007) · Biochemical Journal · doi:10.1042/bj20070081 · Cited by 178
Martins, M., Henriques, M., Lopez‐Ribot, J. L., & Oliveira, R. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02047.x · Cited by 174
Rajendran, R., Williams, C., Lappin, D. F., Millington, O., Martins, M., & Ramage, G. (2013) · Eukaryotic Cell · doi:10.1128/ec.00287-12 · Cited by 173
O’Toole, G. A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.9.2687-2689.2003 · Cited by 171
Production of Monoclonal Antibodies
Yokoyama, W. M. (1999) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb1601s03 · Cited by 169
Relevance of Polymeric Matrix Enzymes During Biofilm Formation
Romaní, A. M., Fund, K., Artigas, J., Schwartz, T., Sabater, S., & Obst, U. (2008) · Microbial Ecology · doi:10.1007/s00248-007-9361-8 · Cited by 165
Development and Validation of an In Vivo Candida albicans Biofilm Denture Model
Nett, J. E., Marchillo, K., Spiegel, C. A., & Andes, D. R. (2010) · Infection and Immunity · doi:10.1128/iai.00480-10 · Cited by 161
Self-citationLattif, A. A., Mukherjee, P. K., Chandra, J., Roth, M. R., Welti, R., Rouabhia, M., & Ghannoum, M. A. (2011) · Microbiology · doi:10.1099/mic.0.051086-0 · Cited by 129
Proteomics for the analysis of the Candida albicans biofilm lifestyle
Thomas, D. P., Bachmann, S. P., & Lopez‐Ribot, J. L. (2006) · PROTEOMICS · doi:10.1002/pmic.200600332 · Cited by 117
Applications of small-angle X-ray scattering to biomacromolecular solutions
Petoukhov, M. V., & Svergun, D. I. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.10.017 · Cited by 115
Production of Monoclonal Antibodies
Yokoyama, W. M., Christensen, M., Santos, G. D., Miller, D. M., Ho, J., Wu, T., Dziegelewski, M., & Neethling, F. A. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im0205s102 · Cited by 114
Secreted Proteases Control Autolysin-mediated Biofilm Growth of Staphylococcus aureus
Chen, C., Krishnan, V., Macon, K. J., Manne, K., Narayana, S. V. L., & Schneewind, O. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.502039 · Cited by 113
Molecular organization of the cell wall of Candida albicans
Klis, F. M., De Groot, P., & Hellingwerf, K. (2001) · Medical Mycology · doi:10.1080/744118876 · Cited by 111
β‐1,3 Glucan as a Test for Central Venous Catheter Biofilm Infection
Nett, J. E., Lincoln, L. M., Marchillo, K., & Andes, D. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/517522 · Cited by 103
Self-citationMartínez‐Gomariz, M., Perumal, P., Mekala, S., Nombela, C., Chaffin, W. L., & Gil, C. (2009) · PROTEOMICS · doi:10.1002/pmic.200700594 · Cited by 101 · cited 1×
“from a previous study identified a number of similarities, including an abundance of proteins involved in carbohydrate and amino acid metabolism (45, 46).”
ResultDalvit, C., Flocco, M. M., Veronesi, M., & Stockman, B. J. (2002) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207023329923 · Cited by 91
Identification of Biofilm Matrix-Associated Proteins from an Acid Mine Drainage Microbial Community
Jiao, Y., D’haeseleer, P., Dill, B. D., Shah, M. B., VerBerkmoes, N. C., Hettich, R. L., Banfield, J. F., & Thelen, M. P. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.03005-10 · Cited by 82
Beauvais, A., Loussert-Fonta, C., Prévost, M. C., Verstrepen, K. J., & Latgé, J. P. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00482.x · Cited by 77
Hwang, T., & Shaka, A. J. (1998) · Journal of Magnetic Resonance · doi:10.1006/jmre.1998.1598 · Cited by 75
Lowman, D. W., West, L. J., Bearden, D. W., Wempe, M. F., Power, T. D., Ensley, H. E., Haynes, K., Williams, D. L., & Kruppa, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027614 · Cited by 74
Bink, A., Kucharíková, S., Neirinck, B., Vleugels, J., Dijck, P. V., Cammue, B. P. A., & Thevissen, K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis594 · Cited by 71
A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis
Nosanchuk, J. D., Nimrichter, L., Casadevall, A., & Rodrigues, M. L. (2008) · Communicative & Integrative Biology · doi:10.4161/cib.1.1.6639 · Cited by 59
Henry, R. J., Blakeney, A. B., Harris, P. J., & Stone, B. (1983) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)88259-5 · Cited by 58
Koenig, S., Svergun, D. I., Koch, M. H. J., Huebner, G., & Schellenberger, A. (1992) · Biochemistry · doi:10.1021/bi00152a007 · Cited by 57
Visualizing Gene Expression Data via Voronoi Treemaps
Bernhardt, J., Funke, S., Hecker, M., & Siebourg‐Polster, J. (2009) · International Symposium on Voronoi Diagrams in Science and Engineering · doi:10.1109/isvd.2009.33 · Cited by 57
Self-citationProduction of Monoclonal Antibodies
Yokoyama, W. M., Christensen, M., Santos, G. D., & Miller, D. M. (2006) · Current Protocols in Immunology · doi:10.1002/0471142735.im0205s74 · Cited by 54
Fluorescence studies of Hoechst 33342 with supercoiled and relaxed plasmid pBR322 DNA
Sandhu, L. C., Warters, R. L., & Dethlefsen, L. A. (1985) · Cytometry · doi:10.1002/cyto.990060304 · Cited by 53
Shibata, N., Kobayashi, H., Okawa, Y., & Suzuki, S. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03622.x · Cited by 53
Lowman, D. W., Ensley, H. E., Greene, R. R., Knagge, K. J., Williams, D. L., & Kruppa, M. D. (2011) · Carbohydrate Research · doi:10.1016/j.carres.2011.09.029 · Cited by 45
The role of diclofenac sodium in the dimorphic transition in Candida albicans
Ghalehnoo, Z. R., Rashki, A., Najimi, M., & Domínguez, Á. (2009) · Microbial Pathogenesis · doi:10.1016/j.micpath.2009.12.003 · Cited by 44
Protein O- Mannosyltransferase Isoforms Regulate Biofilm Formation in Candida albicans
Peltroche‐Llacsahuanga, H., Goyard, S., d’Enfert, C., Prill, S. K. ‐., & Ernst, J. F. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00606-06 · Cited by 42
Identification of differentially expressed genes from limited amounts of RNA
Bosch, I. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.7.e27 · Cited by 34
Takahashi, S., Kudoh, A., Okawa, Y., & Shibata, N. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08564.x · Cited by 32
The Oil of Adenanthera pavonina L. Seeds and its Emulsions
Żarnowski, R., Jaromin, A., Čertík, M., Czabany, T., Fontaine, J., Jakubík, T., Iqbal, M. C. M., Grandmougin‐Ferjani, A., Kozubek, A., & Pietr, S. J. (2004) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2004-5-605 · Cited by 27
Self-citationThe Bacterial Biofilm Matrix as a Platform for Protein Delivery
Absalon, C., Ymele‐Leki, P., & Watnick, P. I. (2012) · mBio · doi:10.1128/mbio.00127-12 · Cited by 25
Żarnowski, R., Connolly, P., Wheat, L. J., & Woods, J. P. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.03.020 · Cited by 23
Structural and functional characterization of soluble endoglin receptor
Le, B. V., Franke, D., Svergun, D. I., Han, T.-H., Hwang, H., & Kim, K. K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.162 · Cited by 21
A New Paper Chromatography Solvent for Amino-Acids
BRYANT, F., & OVERELL, B. T. (1951) · Nature · doi:10.1038/168167b0 · Cited by 18
Production of Monoclonal Antibodies
Yokoyama, W. M. (1992) · Current Protocols in Immunology · doi:10.1002/0471142735.im0205s03 · Cited by 11
Shibata, N., & Okawa, Y. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.1386 · Cited by 6
Żarnowski, R., Ellis, R. J., Lewicka, T., & Pietr, S. J. (2004) · PubMed · Cited by 4
Gow, N. (2001) · Medical Mycology · doi:10.1080/744118879 · Cited by 1
Cited by
Biofilm Matrixome: Extracellular Components in Structured Microbial Communities
Karygianni, L., Ren, Z., Koo, H., & Thurnheer, T. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.03.016 · Cited by 1,487
The Fungal Cell Wall: Structure, Biosynthesis, and Function
Gow, N. A. R., Latge, J.-P., & Munro, C. A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0035-2016 · Cited by 1,423
“neoformans, while other fungi, such as some Candida species, form biofilms growing on solid surfaces, where the extracellular matrix has a more loose structure composed of glucans, chitin, nucleic acids, and other polymers (25, 26).”
BackgroundCandida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Candida albicans biofilms: development, regulation, and molecular mechanisms
Gulati, M., & Nobile, C. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.01.002 · Cited by 738
Candida Biofilms: Threats, Challenges, and Promising Strategies
Cavalheiro, M., & Teixeira, M. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00028 · Cited by 690
“α-1,2-Branched α-1,6-mannans were the more abundant polysaccharides found associated with unbranched α-1,6-glucans, forming a mannan–glucan complex on the matrix (42).”
Background
Metadata
- Authors
- Zarnowski, R., Westler, W. M., Lacmbouh, G. A., Marita, J. M., Bothe, J. R., Bernhardt, J., Lounes-Hadj Sahraoui, A., Fontaine, J., Sanchez, H., Hatfield, R. D., Ntambi, J. M., Nett, J. E., Mitchell, A. P., & Andes, D. R.
- Affiliations
- Department of Medicine, Infectious Diseases, University of Wisconsin, Madison, Wisconsin, USA
- University of Wisconsin–Madison (US)
- U.S. Dairy Forage Research Center (US)
- Universität Greifswald (DE)
- Université du Littoral Côte d’Opale, Unité de Chimie Environnementale at Interactions sur le Vivant, Calais, France
- Université du littoral côte d'opale (FR)
- Carnegie Mellon University (US)
- Corresponding author
- Andes, David R.
- ORCID
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2014-08-29
- Volume
- 5
- Issue
- 4
- Pages
- e01333-14
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- PMC
- PMC4128356
- OpenAlex
- W2149297795
- Cited by
- 315
- References
- 98
- Citations by year
- 2026: 18 · 2025: 24 · 2024: 23 · 2023: 23 · 2022: 31 · 2021: 27 · 2020: 34 · 2019: 30 · 2018: 26 · 2017: 27 · 2016: 29 · 2015: 19 · 2014: 4
- FWCI
- 18.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mBio (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- HAL (submittedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by-nc-sa)
- KiltHub Repository
- Funders
- National Science Foundation (8415048, OIA‐9977486, 9214394)
- U.S. Department of Energy
- U.S. Department of Agriculture
- University of Georgia
- National Institutes of Health (5f32gm010399-02, NIH-R01, 2p41rr005351-21)
- National Heart, Lung, and Blood Institute (T32HL007899)
- National Institute of General Medical Sciences (P41GM10399)
- National Institute of Allergy and Infectious Diseases (R01AI067703, R01AI073289)
- National Center for Research Resources (RR-02781, S10RR002781, P41RR002301, S10RR008438, S10RR027000, P41-RR02301, RR-08438, P41-RR005351)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida albicans, fungal biofilms, biofilm matrix composition, β-1,6-glucan, β-1,3-glucan, glycerolipids, antifungal resistance, fluconazole, virulence
- MeSH terms
- Antifungal Agents, Candida albicans, Fungal Proteins, Gene Expression Regulation, Fungal, Biofilms, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.